不育
男性不育
医学
生物
生理学
妇科
怀孕
遗传学
作者
Amarnath Rambhatla,Rupin Shah,Germar M. Pinggera,Taymour Mostafa,Widi Atmoko,Ramadan Saleh,Eric Chung,Taha Abo-Almagd Abdel-Meguid Hamoda,Selahíttín Çayan,Hyun Jun Park,Ateş Kadıoğlu,Logan Hubbard,Ashok Agarwal
出处
期刊:Pharmacological Reviews
[American Society for Pharmacology & Experimental Therapeutics]
日期:2024-10-21
卷期号:: PHARMREV-001085
标识
DOI:10.1124/pharmrev.124.001085
摘要
Male factor infertility is a multifaceted problem that affects approximately 50% of couples suffering from infertility. Causes of male infertility include endocrine disturbances, gonadotoxins, genetic abnormalities, varicocele, malignancies, infections, congenital or acquired urogenital abnormalities, iatrogenic factors, immunological factors, and idiopathic reasons. There are a variety of treatment options for male infertility, depending on the underlying cause(s). These can include surgical treatments, medical/hormonal therapies, and assisted reproductive techniques (ART), which can be combined with surgical sperm retrieval (SSR) if necessary. In this review article, the pharmacological therapies for male infertility are grouped by their underlying causes. Some of these therapies are targeted and specific, while others are used empirically to treat idiopathic male infertility. This will include treatments to optimize infertility in patients who have hypogonadism, ejaculatory dysfunction, infections, or idiopathic male infertility. Finally, we will provide an overview of the future directions of pharmacological therapies for male infertility. Significance Statement Male infertility is a significant worldwide problem. Detailed knowledge of the pharmacological therapies available will ensure the prescription of appropriate therapy and avoid the use of unnecessary or harmful treatments.
科研通智能强力驱动
Strongly Powered by AbleSci AI